ChemicalBook > CAS DataBase List > PF-6260933

PF-6260933

Product Name
PF-6260933
CAS No.
1811510-56-1
Chemical Name
PF-6260933
Synonyms
PF06260933;PF-6260933;[3,3'-Bipyridine]-6,6'-diamine, 5-(4-chlorophenyl)-;PF 06260933;PF06260933;PF6260933;PF 6260933;PF-6260933;inhibit,MAP4K,MAPK Kinase Kinase Kinase,PF 06260933,PF06260933,Inhibitor,PF-06260933
CBNumber
CB53344890
Molecular Formula
C16H13ClN4
Formula Weight
296.75
MOL File
1811510-56-1.mol
More
Less

PF-6260933 Property

Boiling point:
483.8±40.0 °C(Predicted)
Density 
1.330±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMF: 1 mg/ml; DMSO: 1 mg/ml; Ethanol: insol; PBS (pH 7.2): insol
form 
A solid
pka
5.04±0.13(Predicted)
More
Less

Safety

HS Code 
2933998090
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

ChemScene
Product number
CS-8001
Product name
PF-06260933
Purity
98.41%
Packaging
5mg
Price
$144
Updated
2021/12/16
ChemScene
Product number
CS-8001
Product name
PF-06260933
Purity
98.41%
Packaging
10mg
Price
$228
Updated
2021/12/16
ChemScene
Product number
CS-8001
Product name
PF-06260933
Purity
98.41%
Packaging
25mg
Price
$468
Updated
2021/12/16
ChemScene
Product number
CS-8001
Product name
PF-06260933
Purity
98.41%
Packaging
50mg
Price
$660
Updated
2021/12/16
ChemScene
Product number
CS-8001
Product name
PF-06260933
Purity
98.41%
Packaging
100mg
Price
$1020
Updated
2021/12/16
More
Less

PF-6260933 Chemical Properties,Usage,Production

Biological Activity

PF-6260933 is a MAP4K4 inhibitor with IC50 of 3.7 nM and good kinome selectivity.

in vitro

PF-06260933 treatment of human aortic endothelial cell (EC) robustly prevents TNF-α-mediated endothelial permeability in vitro , similar to MAP4K4 knockdown.

< b>

in vivo

In the mice model, PF-06260933 treatment does not alter plasma lipid content, although reductions in glucose levels are observed, which is consistent with whole-body-inducible Map4k4 knockout animals. PF-06260933 administration ameliorates further plaque development and/or promotes plaque regression in this animal model (46.0% versus 25.5%), and a reduction in plasma glucose as well as lipid content is also observed.

p>

target

TargetValue
MAP4K4
()
3.7 nM

PF-6260933 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

PF-6260933 Suppliers

InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6393
Advantage
58
Aladdin Scientific
Tel
+1-833-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
57511
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354
Email
support@targetmol.com
Country
United States
ProdList
19973
Advantage
58